deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 1-arm NCT01996527

3T MRI Biomarkers of Glioma Treatment Response

Early Detection of Glioma Treatment Response Using MRI-Based Biomarkers

Sponsor: National Cancer Institute (NCI)

Conditions Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor
Interventions 3-Tesla magnetic resonance imaging CEST-MRI DCE-MRI DSC-MRI DW-MRI IV administration of gadolinium-containing contrast agent
Updated 7 times since 2017 Last updated: Apr 13, 2017 Started: May 31, 2012 Primary completion: Nov 23, 2015 Completion: Jan 1, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI left institution

Other terminated trials from National Cancer Institute (NCI)

See all terminations from National Cancer Institute (NCI)

This EARLY_PHASE1 trial investigates Adult Anaplastic Astrocytoma and Adult Anaplastic Ependymoma and is currently terminated or withdrawn. National Cancer Institute (NCI) leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotTerminated~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated EARLY_PHASE1

  5. Jun 2017 — Jun 2018 [monthly]

    Terminated EARLY_PHASE1

    Phase: NA → EARLY_PHASE1

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2017 [monthly]

    Terminated NA

  2. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Vanderbilt-Ingram Cancer Center
Data source: Vanderbilt-Ingram Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations